Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M de Witte

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Leukemia Research|March 19, 2008
Does T-cell depletion have a future in allogeneic stem cell transplantation?T M de Witte
Cancer Treatment and Research|November 13, 2001
Biology of stem and myeloid progenitor cells in myelodysplastic syndromesL F Span, T M de Witte
Statistics in Medicine|October 23, 2012
Dynamic prediction by landmarking in competing risksM A Nicolaie, J C van Houwelingen, T M de Witte, et al.
Biometrics|July 20, 2013
Dynamic pseudo-observations: a robust approach to dynamic prediction in competing risksM A Nicolaie, J C van Houwelingen, T M de Witte, et al.
Pharmaceutisch Weekblad. Scientific Edition|December 9, 1988
The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers. A pilot studyW J Wijnands, T J Janssen, P J Guelen, et al.
British Journal of Haematology|February 1, 1997
An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanismT F Smetsers, E H Linders, L T van de Locht, et al.
Vox Sanguinis|January 1, 1988
A fluorescent microsphere method for the investigation of erythrocyte chimaerism after allogeneic bone marrow transplantation using antigenic differencesA J de Man, W J Foolen, B A van Dijk, et al.
Leukemia|September 14, 1999
Idarubicin DNA intercalation is reduced by MRP1 and not PgpM E Smeets, R A Raymakers, G Vierwinden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTLH Dolstra, H Fredrix, F Preijers, et al.
Leukemia|January 1, 1995
Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levelsT F Smetsers, L T van de Locht, A H Pennings, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Leukemia Research|March 19, 2008
Does T-cell depletion have a future in allogeneic stem cell transplantation?T M de Witte
Cancer Treatment and Research|November 13, 2001
Biology of stem and myeloid progenitor cells in myelodysplastic syndromesL F Span, T M de Witte
Statistics in Medicine|October 23, 2012
Dynamic prediction by landmarking in competing risksM A Nicolaie, J C van Houwelingen, T M de Witte, et al.
Biometrics|July 20, 2013
Dynamic pseudo-observations: a robust approach to dynamic prediction in competing risksM A Nicolaie, J C van Houwelingen, T M de Witte, et al.
Pharmaceutisch Weekblad. Scientific Edition|December 9, 1988
The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers. A pilot studyW J Wijnands, T J Janssen, P J Guelen, et al.
British Journal of Haematology|February 1, 1997
An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanismT F Smetsers, E H Linders, L T van de Locht, et al.
Vox Sanguinis|January 1, 1988
A fluorescent microsphere method for the investigation of erythrocyte chimaerism after allogeneic bone marrow transplantation using antigenic differencesA J de Man, W J Foolen, B A van Dijk, et al.
Leukemia|September 14, 1999
Idarubicin DNA intercalation is reduced by MRP1 and not PgpM E Smeets, R A Raymakers, G Vierwinden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTLH Dolstra, H Fredrix, F Preijers, et al.
Leukemia|January 1, 1995
Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levelsT F Smetsers, L T van de Locht, A H Pennings, et al.
Pageof 2